Previous studies have proposed a Warburg-like metabolic phenotype in HER2/neu-positive breast cancer that couples high glycolytic flux with fatty acid synthesis to regenerate reducing equivalents and shuttle carbons into fatty acids [6, 9, 10]. This evidence concerns the gene ERBB2 and breast cancer.